Stock search

Ticker or company name

Compare stocks

Market: US

  • JNJJohnson & Johnson
  • MRKMerck & Co.
  • PFEPfizer

Add stock

Ticker or company

Summary

JNJ
Johnson & Johnson
$282,55Down −1,12%
Year: Up +46%
44/100Best scoreRatio would watch
Open stock page
MRK
Merck & Co.
$144,46Down −2,23%
Year: Up +59%
38/100Ratio would not consider buying
Open stock page
PFE
Pfizer
$28,86Down −0,10%
Year: Up +12%
44/100Best scoreRatio would watch
Open stock page

Verdict

JNJ has the best score (44). JNJ grows revenue the fastest. PFE is the cheapest by forward P/E. JNJ has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckJNJ2 ✓ 3 — 3 ✕MRK2 ✓ 2 — 4 ✕PFE2 ✓ 3 — 3 ✕
P/E vs its history42,9148,540,8
P/E vs industry42,9148,540,8
Forward P/E23,718,710,5
Revenue growth, YoY+7,8%+4,9%+1,3%
EPS growth, YoY−36,4%−87,1%−59,3%
Net margin16,2%3,6%6,3%
Net debt / EBITDAn/a—n/a—n/a—
Free cash flow$20,6 bn$14,7 bn$11,8 bn
Share count over a year+0,8%−0,8%+0,6%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterJNJTTMMRKTTMPFETTMIndustry medianTTM
P/E TTM ↓42,9Worst: 148,5Best: 40,841,8
Forward P/E ↓Worst: 23,718,7Best: 10,512,4
PEG ↓Best: 4,6Worst: 25,7−5,53,3
P/S TTM ↓Worst: 6,95,4Best: 2,63,4
EV/EBITDA ↓28,1Worst: 46,1Best: 24,024,0
P/FCF ↓Worst: 33,524,7Best: 14,014,0

Price, %

  • JNJn/a
  • MRKn/a
  • PFEn/a

Returns

Best WorstNo mark — in between

PeriodJNJMRKPFE
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

JNJMRKPFE
Share of “buy”70%Best: 71%Worst: 38%
Beat the forecastWorst: 3 of 4Best: 4 of 4Best: 4 of 4
Average “surprise”Worst: +0,5%Best: +22,4%+11,7%
Insiders over 12 monthssales $154 msales $70,7 mpurchases $2,83 m

Details are on each stock page.